These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30773756)

  • 81. [Insulin pump treatment in children and adolescents with type 1 diabetes].
    Bittner C; von Schütz W; Danne T
    MMW Fortschr Med; 2004 May; 146(20):35-7. PubMed ID: 15344731
    [No Abstract]   [Full Text] [Related]  

  • 82. Health Care Utilization and Costs of Publicly-Insured Children with Diabetes in California.
    Lee JM; Sundaram V; Sanders L; Chamberlain L; Wise P
    J Pediatr; 2015 Aug; 167(2):449-54.e6. PubMed ID: 26028286
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reimbursement Pathways for New Diabetes Technologies in Europe: Top-Down Versus Bottom-Up.
    Seidel D; Boggio Mesnil F; Caruso A
    J Diabetes Sci Technol; 2019 Jan; 13(1):118-122. PubMed ID: 30033750
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes.
    Datye KA; Tilden DR; Parmar AM; Goethals ER; Jaser SS
    Curr Diab Rep; 2021 May; 21(7):22. PubMed ID: 33991264
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Blood glucose meters and test strips: global market and challenges to access in low-resource settings.
    Klatman EL; Jenkins AJ; Ahmedani MY; Ogle GD
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):150-160. PubMed ID: 30072234
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries.
    Neubert A; Hsia Y; de Jong-van den Berg LT; Janhsen K; Glaeske G; Furu K; Kieler H; Nørgaard M; Clavenna A; Wong IC
    Br J Clin Pharmacol; 2011 Dec; 72(6):969-77. PubMed ID: 21689139
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Considerations for an institution for evaluation of diabetes technology devices to improve their quality in the European Union.
    Heinemann L; Freckmann G; Koschinsky T
    J Diabetes Sci Technol; 2013 Mar; 7(2):542-7. PubMed ID: 23567012
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Preserving Skin Integrity with Chronic Device Use in Diabetes.
    Messer LH; Berget C; Beatson C; Polsky S; Forlenza GP
    Diabetes Technol Ther; 2018 Jun; 20(S2):S254-S264. PubMed ID: 29916740
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diabetes Technology Experiences Among Latinx and Non-Latinx Youth with Type 1 Diabetes.
    Tsai D; Flores Garcia J; Fogel JL; Wee CP; Reid MW; Raymond JK
    J Diabetes Sci Technol; 2022 Jul; 16(4):834-843. PubMed ID: 34225480
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Use of Technology in Managing Diabetes in Youth Part 2-Insulin Pump Technologies: Information and Tips for the School Nurse.
    Berget C; Wyckoff L
    NASN Sch Nurse; 2020 Jul; 35(4):188-195. PubMed ID: 32484746
    [TBL] [Abstract][Full Text] [Related]  

  • 91. COMPARATIVE PHARMACOECONOMIC ANALYSIS OF SELF-CONTROL OF DIABETES MELLITUS USING GLUCOMETERS.
    Vlasenko IO; Babileva AA; Kurashvili RB; Davtian LL
    Wiad Lek; 2022; 75(5 pt 1):1105-1111. PubMed ID: 35758486
    [TBL] [Abstract][Full Text] [Related]  

  • 92. "Out of the box" solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray.
    Paret M; Barash G; Rachmiel M
    Acta Diabetol; 2020 Apr; 57(4):419-424. PubMed ID: 31705297
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Diabetes device reimbursement in the EU-5.
    Schäfer E; Schnell G; Bobáková T
    J Diabetes Sci Technol; 2013 Jul; 7(4):1084-92. PubMed ID: 23911192
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Diabetes Technology and Therapy in the Pediatric Age Group.
    Maahs DM; Lal R; Shalitin S
    Diabetes Technol Ther; 2019 Feb; 21(S1):S123-S137. PubMed ID: 30785328
    [No Abstract]   [Full Text] [Related]  

  • 95. Technology Use in Transition-Age Patients With Type 1 Diabetes: Reality and Promises.
    Los E; Ulrich J; Guttmann-Bauman I
    J Diabetes Sci Technol; 2016 May; 10(3):662-8. PubMed ID: 26892506
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Diabetes and technology: A pilot study on the management of patients with insulin pumps during the COVID-19 pandemic.
    Petrelli F; Cangelosi G; Scuri S; Pantanetti P; Lavorgna F; Faldetta F; De Carolis C; Rocchi R; Debernardi G; Florescu A; Nittari G; Sagaro GG; Garda G; Nguyen CTT; Grappasonni I
    Diabetes Res Clin Pract; 2020 Nov; 169():108481. PubMed ID: 33002544
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Integration of Consumer-Based Activity Monitors into Clinical Practice for Children with Type 1 Diabetes: A Feasibility Study.
    Jaggers JR; McKay T; King KM; Thrasher BJ; Wintergerst KA
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682355
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Skin and adhesive issues with continuous glucose monitors: a sticky situation.
    Englert K; Ruedy K; Coffey J; Caswell K; Steffen A; Levandoski L;
    J Diabetes Sci Technol; 2014 Jul; 8(4):745-51. PubMed ID: 24876416
    [TBL] [Abstract][Full Text] [Related]  

  • 99. High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey.
    Lombardo F; Passanisi S; Tinti D; Messina MF; Salzano G; Rabbone I
    J Diabetes Sci Technol; 2021 Nov; 15(6):1377-1381. PubMed ID: 32757778
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The CGM grey market: a reflection of global access inequity.
    Onisie O; Crocket H; de Bock M
    Lancet Diabetes Endocrinol; 2019 Nov; 7(11):823-825. PubMed ID: 31427219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.